Ikapharmindo Putramas Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 400 24h volume), while Venteny Fortuna International Tbk. trades at Rp64 (market cap 394.71B, 8.37M 24h volume). The key difference: Venteny Fortuna International Tbk. is the larger of the two by market cap, and Venteny Fortuna International Tbk. is more actively traded (8.37M versus 400). Which is the better fit depends on your goals.
| IKPM | VTNY | |
|---|---|---|
Market Cap | 308.29B | 394.71B |
Volume | 400 | 8.37M |
Lot | 4 | 83.74K |
Turnover | 73.2K | 527.69M |
Average Price | 183 | 63.02 |
Value | 73.2K | 527.69M |
Indicative Equilibrium Price | 183 | 64 |
Indicative Equilibrium Volume | 100 | 2.53K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →